Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BMYMP - Bristol Plavix Setback And Other News: The Good Bad And Ugly Of Biopharma


BMYMP - Bristol Plavix Setback And Other News: The Good Bad And Ugly Of Biopharma

Bristol-Myers Squibb Faces Setback in Plavix Litigation

Bristol-Myers Squibb (BMY) reported that a Hawaii district court has dismissed its countersuit against the State of Hawaii. The company is currently in an altercation with the state with regard to Plavix drug and its marketing. The Plavix trial is scheduled to be started in May 5, but it is highly likely that the date may now be postponed on account of COVID-19 pandemic. The company is fighting against an $8 billion lawsuit by Hawaii pertaining marketing of Plavix.

Bristol-Myers Squibb contends that the state is infringing upon

Read more ...

Stock Information

Company Name: Bristol-Myers Squibb $2Pr
Stock Symbol: BMYMP
Market: OTC
Website: bms.com

Menu

BMYMP BMYMP Quote BMYMP Short BMYMP News BMYMP Articles BMYMP Message Board
Get BMYMP Alerts

News, Short Squeeze, Breakout and More Instantly...